Kestra CEO logs tax-withholding share sales
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies president and CEO Brian Daniel Webster reported sales of 29,822 common shares of KMTS in three transactions on July 30, July 31 and August 3, 2026. The shares were sold at weighted average prices between $22.0577 and $24.1100 solely to cover tax withholding obligations from the vesting and settlement of restricted stock units.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares F1, F4 | 13,017 | $23.9244 | $311K |
| Sale | Common Shares F1, F3 | 8,948 | $22.6039 | $202K |
| Sale | Common Shares F1, F2 | 7,857 | $22.7225 | $179K |
Footnotes (4)
- F1. The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
- F2. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.2524 to $23.1700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
- F3. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.0577 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
- F4. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.6400 to $24.1100. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Key Figures
Key Terms
sell to cover transactions financial
weighted average price financial
restricted stock units financial
tax withholding obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Kestra Medical (KMTS) report in this Form 4?
What does “weighted average price” mean in the KMTS CEO’s Form 4 footnotes?
Were the KMTS CEO’s sales made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.